Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol COL18A1 contributors: SGE - updated : 18-01-2018
HGNC name collagen, type XVIII, alpha 1
HGNC id 2195
PROTEIN
PHYSICAL PROPERTIES globular
STRUCTURE
motifs/domains
  • thrombospondin N-terminal-like domain with a zinc-binding site (its integrity is essential
  • for the stability and biological functions of endostatin)
  • ten interrupted triple helical domains
  • non triple helical regions with the 184 C terminal residues corresponding to endostatin
  • conjugated GlycoP
    mono polymer homomer , trimer
    isoforms Precursor precursor of endostatin (a potent antiangiogenic protein) which is proteolytically produced by the C-terminal fragment of type XVIII collagen
    HOMOLOGY
    interspecies homolog to murine Col18a1 (80.3pc)
    homolog to rattus Col18a1 (79.6pc)
    Homologene
    FAMILY
  • fibril-associated collagens with interrupted helices (FACIT) family
  • multiplexin collagen family
  • CATEGORY adhesion , structural protein
    SUBCELLULAR LOCALIZATION extracellular
    text
  • extracellular matrix, part of basement membrane molecular networks
  • colocalized with TGM2 in the extracellular matrix secreted by endothelial cells under hypoxia, which stimulates angiogenesis
  • basic FUNCTION
  • playing an important role in retinal structure, in eye organization and in neural tube closure
  • maintaining the structure of connective tissue
  • inhibiting endothelial cell proliferation (G(1) arrest) by down-regulation of the cyclin D1 promoter and angiogenesis (endostatin)
  • inhibiting angiogenesis by binding to the heparan sulphate proteoglycans and promoting formation of focal adhesion and actin stress fibers
  • involved in growth factor signaling
  • decreasing the hyperphosphorylated retinoblastoma gene product and down-regulating cyclin D1 mRNA and protein (endostatin)
  • playing an essential role for RPE function, and suggest an important role of this collagen in Bruch's membrane
  • endogenous inhibitor of angiogenesis, that inhibits proliferation and migration of endothelial cells
  • N-terminal integrity is very critical for its stability
  • and biological functions and expression systems make a huge difference with respect to the properties of endostatin
  • anti-angiogenic molecules, such as CNMD and COL18A1, have pivotal roles in preserving the avascularity of cartilage
  • promotes soft callus formation but inhibits callus remodeling during fracture healing most probably by an inhibition of angiogenesis
  • has a specific activity, independent of baseline synapse development, that is required for the homeostatic modulation of presynaptic calcium influx and neurotransmitter release
  • endogenous angiogenesis inhibitor with broad-spectrum antitumor activities
  • has novel ATPase activity, which mediates its antiangiogenic and antitumor activities
  • antiangiogenic factor, that is enriched in aging kidneys
  • kidney fibrosis in aging may represent a natural outcome of upregulated COL18A1 and TGM2, but more likely it appears to be a result of cumulative stresses occurring on the background of synergistically acting geronic (aging) proteins, COL18A1 and TGM2
  • CELLULAR PROCESS cell life, proliferation/growth
    PHYSIOLOGICAL PROCESS development
    text
  • histogenesis and organogenesis
  • negative control of cell proliferation
  • PATHWAY
    metabolism
    signaling sensory transduction/vision
    a component
    INTERACTION
    DNA
    RNA
    small molecule metal binding,
  • Zn2+ binding
  • protein
  • binding to the heparan sulphate proteoglycans
  • binding to ITGA5 beta1 (to the inhibition of focal adhesion kinase MAP2K1, mitogen -activated protein kinase pathway)
  • endogenous angiogenesis inhibitor which requires E-selectin for its antiangiogenic activity
  • interacting with Integrin-heparan sulfate (may play a role in endostatin signaling by contributing to its localization to lipid rafts at the surface of endothelial cells) (Boniface 2009)
  • interacting with receptor nucleolin
  • interaction with TGM2 might participate in the concerted regulation of angiogenesis and tumorigenesis by COL18A1 and TGM2
  • cysteine cathepsins S and L modulate anti-angiogenic activities of COL18A1
  • interaction between COL18A1 short peptide and FLT4
  • COL18A1 is an interactive partner of transglutaminase 2 (TGM2), an enzyme that cross-links extracellular matrix proteins
  • cell & other
    REGULATION
    Other excess of the COL18A1 Tsp-1 domain is deleterious in the eye, possibly by impairing certain functions of the full-length molecule
    ASSOCIATED DISORDERS
    corresponding disease(s) KNO
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    constitutional     --over  
    in primary Sjögren syndrome, particularly in those with interstitial lung disease (ILD)
    Susceptibility to age-related macular degeneration
    Variant & Polymorphism other
  • polymorphism at position 1437 in prostate cancer (heterozygous Asn-1437 individuals have a 2.5 times increased chance of developing prostate cancer as compared with homozygous Asp-1437 individuals)
  • allele N104 for the endostatin domain represent a modifier allele for disorder in which angiogenesis is important, such a cancer
  • SNP in COL18A1 are associated with hepatopulmonary syndrome
  • Candidate gene
  • high expression is associated with poor prognosis in patients with metastatic carcinoma
  • Marker
  • serum COL18A1 as a potential biomarker in
  • Pulmonary arterial hypertension (PAH) with the capacity to predict poor outcomes
    Therapy target
    SystemTypeDisorderPubmed
    cancerangiogenesis 
    construction of endostatin analogues with high ATPase activity may provide a new direction for the development of more potent antiangiogenic drugs
    neurosensorialvisual 
    therapeutic up-regulation may be a new strategy in the treatment of neovascular AMD (age-related macular degeneration)
    respiratorylung 
    COL18A1/ES is a potential new therapeutic target in Pulmonary arterial hypertension (PAH)
    miscelleaneoushypertension 
    coadministration of COL18A1 with VEGFA inhibitors may offer a unique strategy to prevent drug-related hypertension and enhance antiangiogenic tumor suppression
    ANIMAL & CELL MODELS
  • Collagen XVIII deficiency leads to anterior and posterior eye defects in Col18a1(-/-) mice
  • Col18a1(-/-) mice showed effacement of the glomerular podocyte foot processes, and microindentation studies showed changes in the mechanical properties of the glomeruli